Varex Imaging (NASDAQ:VREX) Cut to “Market Perform” at CJS Securities

CJS Securities lowered shares of Varex Imaging (NASDAQ:VREX) from an outperform rating to a market perform rating in a research report report published on Monday, Marketbeat Ratings reports.

Other equities analysts also recently issued research reports about the company. Sidoti restated a “neutral” rating and set a $19.00 target price on shares of Varex Imaging in a research report on Monday, August 10th. Oppenheimer lowered Varex Imaging from an “outperform” rating to a “market perform” rating in a research note on Monday, August 10th. Wall Street Zen upgraded Varex Imaging from a “hold” rating to a “buy” rating in a research report on Saturday, July 4th. Weiss Ratings upgraded Varex Imaging from a “sell (d-)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Finally, B. Riley Financial cut Varex Imaging from a “buy” rating to a “hold” rating in a report on Monday, August 10th. Six investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $16.88.

Varex Imaging Stock Performance

NASDAQ:VREX opened at $18.46 on Monday. Varex Imaging has a 12-month low of $9.09 and a 12-month high of $18.63. The company has a quick ratio of 1.53, a current ratio of 3.38 and a debt-to-equity ratio of 0.64. The firm has a market capitalization of $777.17 million, a PE ratio of 35.50 and a beta of 0.89. The firm has a 50-day moving average price of $12.08 and a 200 day moving average price of $11.76.

Varex Imaging (NASDAQ:VREX) last announced its quarterly earnings results on Monday, August 10th. The company reported $0.31 EPS for the quarter, topping analysts’ consensus estimates of $0.21 by $0.10. The firm had revenue of $210.50 million during the quarter, compared to analysts’ expectations of $215.50 million. Varex Imaging had a net margin of 2.55% and a return on equity of 9.19%. Research analysts anticipate that Varex Imaging will post 0.98 earnings per share for the current fiscal year.

Institutional Trading of Varex Imaging

Several hedge funds have recently modified their holdings of VREX. Rockefeller Capital Management L.P. acquired a new position in shares of Varex Imaging in the 4th quarter worth approximately $27,000. Legal & General Group Plc bought a new stake in Varex Imaging during the 2nd quarter worth approximately $43,000. Quarry LP acquired a new stake in Varex Imaging during the 3rd quarter valued at $64,000. BNP Paribas Financial Markets increased its holdings in Varex Imaging by 18.5% during the 2nd quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares in the last quarter. Finally, Aquatic Capital Management LLC acquired a new stake in Varex Imaging during the 3rd quarter valued at $117,000.

Varex Imaging Company Profile

Varex Imaging Corporation is a global provider of X-ray imaging components and solutions for the medical, security and industrial markets. The company designs, develops and manufactures a broad range of products that convert X-ray energy into high-resolution digital images. Its portfolio includes X-ray tubes, flat panel detectors, digital sensors, specialty radiographic tubes and related software, all engineered to meet the demanding requirements of original equipment manufacturers (OEMs) in diagnostic imaging, computed tomography (CT), fluoroscopy, mammography, dental radiography and non-destructive testing applications.

The company’s medical imaging offerings support a wide spectrum of clinical modalities, from portable radiography systems to advanced CT scanners, enhancing image quality and dose efficiency for healthcare providers.